United States Immuno Chemistry Market Outlook to 2024

Published : Nov-2017

No. of Pages : 342

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 2
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Immuno Chemistry Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 8
3 Immuno Chemistry Market, United States 12
3.1 Immuno Chemistry Market, United States, Revenue ($m), 2010-2017 12
3.2 Immuno Chemistry Market, United States, Revenue ($m), 2017-2024 14
3.3 Immuno Chemistry Market, United States, Volume (Units), 2010-2017 48
3.4 Immuno Chemistry Market, United States, Volume (Units), 2017-2024 50
3.5 Immuno Chemistry Market, United States, Average Price ($), 2010-2024 84
3.6 Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), 2017 89
3.7 Immuno Chemistry Market, United States, Company Share by Revenue ($m), 2017 90
4 Overview of Key Companies in United States, Immuno Chemistry Market 92
4.1 Siemens Healthcare GmbH 92
4.2 F. Hoffmann-La Roche Ltd 92
4.3 Abbott Laboratories 92
4.4 Beckman Coulter Inc 92
4.5 DiaSorin S.p.A 93
4.6 Thermo Fisher Scientific Inc 93
4.7 bioMerieux SA 93
4.8 Bio-Rad Laboratories Inc 93
4.9 Ortho-Clinical Diagnostics Inc 94
4.10 Alere Inc 94
5 Immuno Chemistry Market Pipeline Products 95
6 Financial Deals Landscape 98
6.1 Acquisition 98
6.2 Debt Offerings 99
6.3 Equity Offerings 136
6.4 Merger 153
6.5 Partnerships 154
6.6 Venture Financing 156
7 Recent Developments 163
7.1 Corporate Communications 163
7.2 Financial Announcements 194
7.3 Government and Public Interest 297
7.4 Legal And Regulatory 299
7.5 Other Significant Developments 307
7.6 Product News 316
7.7 Strategy And Business Planning 323
8 Appendix 329
8.1 Research Methodology 330
8.2 GlobalData Consulting 334
8.3 Contact Us 335
8.4 Disclaimer 335

1.1 List of Tables
Table 1: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 20
Table 2: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 22
Table 3: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 24
Table 4: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 26
Table 5: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 28
Table 6: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 30
Table 7: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 32
Table 8: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 34
Table 9: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 36
Table 10: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 38
Table 11: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 40
Table 12: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 42
Table 13: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 44
Table 14: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 46
Table 15: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 48
Table 16: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 50
Table 17: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 52
Table 18: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 54
Table 19: Immuno Chemistry Market, United States, Volume (Units), Historic, 2010-2017 56
Table 20: Immuno Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 58
Table 21: Complement Deficiency Tests Market, United States, Volume (Units), Historic, 2010-2017 60
Table 22: Diabetes Assays Market, United States, Volume (Units), Historic, 2010-2017 62
Table 23: Disease Specific Immunochemistry Market, United States, Volume (Units), Historic, 2010-2017 64
Table 24: Endocrinology Tests Market, United States, Volume (Units), Historic, 2010-2017 66
Table 25: IgE Allergy Blood Tests Market, United States, Volume (Units), Historic, 2010-2017 68
Table 26: Immunochemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 70
Table 27: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 72
Table 28: Vitamins Tests Market, United States, Volume (Units), Historic, 2010-2017 74
Table 29: Complement Deficiency Tests Market, United States, Volume (Units), Forecast, 2017-2024 76
Table 30: Diabetes Assays Market, United States, Volume (Units), Forecast, 2017-2024 78
Table 31: Disease Specific Immunochemistry Market, United States, Volume (Units), Forecast, 2017-2024 80
Table 32: Endocrinology Tests Market, United States, Volume (Units), Forecast, 2017-2024 82
Table 33: IgE Allergy Blood Tests Market, United States, Volume (Units), Forecast, 2017-2024 84
Table 34: Immunochemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 86
Table 35: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 88
Table 36: Vitamins Tests Market, United States, Volume (Units), Forecast, 2017-2024 90
Table 37: Immuno Chemistry Market, United States, Average Price ($) Historic, 2010-2017 91
Table 38: Immuno Chemistry Market, United States, Average Price ($), Forecast, 2017-2024 94
Table 39: Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 96
Table 40: Immuno Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2017 98
Table 41: Immuno Chemistry Market Pipeline Products 102
Table 42: One Lambda Acquires Linkage Biosciences 105
Table 43: Amgen Raises USD1 Billion in Public Offering of 3.2% Notes Due 2027 106
Table 44: Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 108
Table 45: MEDITE Cancer Diagnostics Raises USD5.4 Million in Private Placement of Convertible Promissory Notes 109
Table 46: LabCorp Raises USD600 Million in Public Offering of 3.25% Notes Due 2024 110
Table 47: LabCorp Raises USD600 Million in Public Offering of 3.6% Notes Due 2027 112
Table 48: Thermo Fisher Scientific Raises USD750 Million in Public Offering of 4.1% Notes Due 2047 114
Table 49: Thermo Fisher Scientific Raises USD750 Million in Public Offering of 3.2% Notes Due 2027 116
Table 50: Thermo Fisher Scientific Raises USD573.3 Million in Public Offering of Floating Rate Notes Due 2019 118
Table 51: Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.4% Notes Due 2026 120
Table 52: Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.95% Notes Due 2029 123
Table 53: Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 2.875% Notes Due 2037 126
Table 54: Becton, Dickinson to Raise USD725 Million in Public Offering of 2.133% Notes Due 2019 129
Table 55: Becton, Dickinson to Raise USD1 Billion in Public Offering of 2.404% Notes Due 2020 130
Table 56: Becton, Dickinson to Raise USD1.8 Billion in Public Offering of 2.894% Notes Due 2022 131
Table 57: Becton, Dickinson to Raise USD500 Million in Public Offering of Floating Rate Notes Due 2022 132
Table 58: Becton, Dickinson to Raise USD1.75 Billion in Public Offering of 3.363% Notes Due 2024 133
Table 59: Becton, Dickinson to Raise USD2.4 Billion in Public Offering of 3.7% Notes Due 2027 134
Table 60: Becton, Dickinson to Raise USD1.5 Billion in Public Offering of 4.669% Notes Due 2047 135
Table 61: Becton, Dickinson to Raise USD788 Million in Public Offering of 0.368% Notes Due 2019 136
Table 62: Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million 137
Table 63: Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million 139
Table 64: Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million 141
Table 65: Trovagene Files Registration Statement to Raise up to USD17.5 Million in Public Offering of Shares 143
Table 66: Trovagene Plans to Raise Funds through Public Offering of Shares upon Exercise of Warrants 144
Table 67: T2 Biosystems Raises USD20 Million in Public Offering of Shares 145
Table 68: Thermo Fisher Scientific Prices Public Offering of Shares for USD1.5 Billion 147
Table 69: MetaStat Raises USD2.1 Million in First Tranche of Private Placement of Shares and Preferred Shares 149
Table 70: GenMark Diagnostics Prices Public Offering of Shares for USD75 Million 150
Table 71: Becton Dickinson Raises USD2.47 Billion in Public Offering of Shares 152
Table 72: Becton Dickinson Raises USD2.47 Billion in Public Offering of Depositary Shares 154
Table 73: HTG Molecular Diagnostics to Raise up to USD20 Million in Public Offering of Shares 156
Table 74: T2 Biosystems Files Registration Statement for Public Offering of Shares 157
Table 75: Corindus Vascular Robotics Raises USD45 Million in Private Placement of Shares 158
Table 76: Grail to Merge with Cirina 160
Table 77: OncoSec Medical Enters into Agreement with Jounce Therapeutics 161
Table 78: Singulex Enters into Agreement with Qiagen 162
Table 79: BioMedomics Raises USD0.5 Million in Venture Financing 163
Table 80: Biodesix Raises USD13.2 Million in Venture Financing 164
Table 81: Akonni Biosystems Raises USD4 Million in Venture Financing 165
Table 82: Armune BioScience Raises USD0.5 Million in Venture Financing 166
Table 83: Integrated Diagnostics Raises USD6 Million in Series C Financing 167
Table 84: Integrated Diagnostics Raises USD6.1 Million in Venture Financing 168
Table 85: Genalyte Raises USD36 Million in Series D Financing 169
Table 86: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 339

1.2 List of Figures
Figure 1: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 19
Figure 2: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 21
Figure 3: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 23
Figure 4: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 25
Figure 5: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 27
Figure 6: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 29
Figure 7: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 31
Figure 8: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 33
Figure 9: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 35
Figure 10: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 37
Figure 11: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 39
Figure 12: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 41
Figure 13: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 43
Figure 14: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 45
Figure 15: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 47
Figure 16: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 49
Figure 17: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 51
Figure 18: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 53
Figure 19: Immuno Chemistry Market, United States, Volume (Units), Historic, 2010-2017 55
Figure 20: Immuno Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 57
Figure 21: Complement Deficiency Tests Market, United States, Volume (Units), Historic, 2010-2017 59
Figure 22: Diabetes Assays Market, United States, Volume (Units), Historic, 2010-2017 61
Figure 23: Disease Specific Immunochemistry Market, United States, Volume (Units), Historic, 2010-2017 63
Figure 24: Endocrinology Tests Market, United States, Volume (Units), Historic, 2010-2017 65
Figure 25: IgE Allergy Blood Tests Market, United States, Volume (Units), Historic, 2010-2017 67
Figure 26: Immunochemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 69
Figure 27: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 71
Figure 28: Vitamins Tests Market, United States, Volume (Units), Historic, 2010-2017 73
Figure 29: Complement Deficiency Tests Market, United States, Volume (Units), Forecast, 2017-2024 75
Figure 30: Diabetes Assays Market, United States, Volume (Units), Forecast, 2017-2024 77
Figure 31: Disease Specific Immunochemistry Market, United States, Volume (Units), Forecast, 2017-2024 79
Figure 32: Endocrinology Tests Market, United States, Volume (Units), Forecast, 2017-2024 81
Figure 33: IgE Allergy Blood Tests Market, United States, Volume (Units), Forecast, 2017-2024 83
Figure 34: Immunochemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 85
Figure 35: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 87
Figure 36: Vitamins Tests Market, United States, Volume (Units), Forecast, 2017-2024 89
Figure 37: Immuno Chemistry Market, United States, Company Share (%) 2017 97

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Human T-Lymphotropic Virus (HTLV) Test (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human T-Lymphotropic Virus (HTLV) Test (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human T-Lymphotropic Virus (HTLV) Test (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human T-Lymphotropic Virus (HTLV) is a retrovirus that infects T Lymphocyte cells. There are four strains of HTLV, out of these HTLV-I and HTLV-II are the most prevalent. HTLV-I is the causative agent of two severe neurological diseases. Specifically, sources indicate that up to 3-5% of patients infected with HTLV-I develop adult T-cell Leukemia/Lymphoma (ATLL) or HTLV-I-associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). Conversely, HTLV-II has been linked to elevate......	$7500

United States Immuno Chemistry Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Human T-Lymphotropic Virus (HTLV) Test (In Vitro Diagnostics) – Global Market Analysis and Forecast Model